| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 156.69B | 162.95B | 153.02B | 146.75B | 128.16B | 94.79B |
| Gross Profit | 54.58B | 55.41B | 53.12B | 51.95B | 43.70B | 28.09B |
| EBITDA | 33.30B | 35.53B | 33.27B | 31.61B | 23.93B | 11.67B |
| Net Income | 18.29B | 15.89B | 18.18B | 12.57B | 8.32B | 5.20B |
Balance Sheet | ||||||
| Total Assets | 198.07B | 220.44B | 209.32B | 211.39B | 188.62B | 180.39B |
| Cash, Cash Equivalents and Short-Term Investments | 24.12B | 48.84B | 41.95B | 49.69B | 71.81B | 68.21B |
| Total Debt | 44.38B | 54.88B | 53.59B | 64.44B | 44.65B | 47.81B |
| Total Liabilities | 81.53B | 95.09B | 91.45B | 102.39B | 80.70B | 75.22B |
| Stockholders Equity | 115.48B | 124.10B | 116.80B | 107.96B | 106.74B | 103.76B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.31B | 9.60B | -18.93B | 17.41B | 11.90B |
| Operating Cash Flow | 0.00 | 25.10B | 24.66B | 26.80B | 24.87B | 18.16B |
| Investing Cash Flow | 0.00 | -11.04B | -11.45B | -55.91B | -12.10B | -9.30B |
| Financing Cash Flow | 0.00 | -7.20B | -20.90B | 6.93B | -9.49B | -8.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥173.34B | 11.00 | ― | 3.40% | 6.49% | -11.12% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥233.70B | 12.92 | ― | 1.51% | ― | ― | |
53 Neutral | ¥185.43B | 15.79 | 3.83% | 4.02% | 76.95% | -10.67% | |
53 Neutral | ¥91.07B | 18.63 | ― | ― | 52.78% | -7.69% | |
51 Neutral | ¥50.11B | 17.63 | ― | ― | 6.93% | ― | |
48 Neutral | ¥63.07B | -0.07 | -78.01% | ― | 4.03% | -747.77% |